Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)

doi:10.1186/1471-2334-9-131

Study protocol

Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)

Cees van Nieuwkoop^*, Jan W van't Wout, Willem JJ Assendelft, Henk W Elzevier, Eliane MS Leyten, Ted Koster, G Hanke Wattel-Louis, Nathalie M Delfos, Hans C Ablij, Ed J Kuijper, Jan Pander, Jeanet W Blom, Ida C Spelt and Jaap T van Dissel

* Corresponding author: Cees van Nieuwkoop c.van_nieuwkoop@lumc.nl

BMC Infectious Diseases 2009, 9:131 doi:10.1186/1471-2334-9-131

No comments have yet been made on this article.

BMC Infectious Diseases

Viewing options

Associated material

Tools

Share this article

Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)

BMC Infectious Diseases

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days)